
Presenter(s): Phillip Coffin, MD
Target Audience: This activity is designed for physicians, nurses, psychologists, social workers, physician assistants, pharmacists, interprofessional team, residents/fellows, medical students, other mental health clinicians. This activity is accredited for physicians, nurses, social workers, physician assistants, pharmacists, interprofessional team, and other health professionals.
Credit Designations Available: AMA PRA Category 1 Credit™, AAPA Category 1 CME, Social Work CE Credit, Nursing Contact Hours, Pharmacy CE Credit, Interprofessional Continuing Education (IPCE) Credit
Webinar Description: This educational activity, presented by Dr. Phillip Coffin, explores the evolving landscape of methamphetamine use amidst the growing presence of fentanyl. Attendees will gain insights into current morbidity and mortality trends, the physiological mechanisms behind methamphetamine toxicity, and evidence-based interventions for managing methamphetamine use disorder (MeUD). Emphasis will be placed on comprehensive prevention, treatment strategies, and addressing the long-term cardiovascular and neuropsychiatric impacts associated with chronic use.
Educational Objectives:
- Analyze current trends in morbidity and mortality related to methamphetamine use in the U.S. and their impact on public health.
- Explain the primary causes and mechanisms contributing to deaths from methamphetamine toxicity, distinguishing between acute and chronic effects.
- Evaluate evidence-based interventions for the treatment of methamphetamine use disorder including pharmacological and behavioral approaches.